Operating Income (Loss) in USD of Applied Therapeutics, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Applied Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2018 to Q3 2025.
  • Applied Therapeutics, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$16.8M, a 43.7% increase year-over-year.
  • Applied Therapeutics, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$98.4M, a 6.63% decline year-over-year.
  • Applied Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$104M, a 61.6% decline from 2023.
  • Applied Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$64.5M, a 22.2% increase from 2022.
  • Applied Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$83M, a 21.5% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Applied Therapeutics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$98.4M -$16.8M +$13M +43.7% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$111M -$23.1M -$2.66M -13% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 -$109M -$25.5M -$4.43M -21% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$104M -$33M -$12M -57.2% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$92.3M -$29.7M -$14.2M -92% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$78M -$20.4M -$3.26M -19% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$74.8M -$21.1M -$10.2M -94.3% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024
Q4 2023 -$64.5M -$21M -$2.03M -10.7% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$62.5M -$15.5M +$3.86M +19.9% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$66.4M -$17.2M +$4.35M +20.2% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 -$70.7M -$10.9M +$12.2M +53% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$83M -$19M +$8.14M +30% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 -$91.1M -$19.4M +$9.07M +31.9% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$100M -$21.5M +$4.35M +16.8% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$105M -$23.1M +$1.1M +4.54% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$106M -$27.1M -$3.36M -14.1% 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 -$102M -$28.4M +$1.54M +5.12% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$104M -$25.9M +$2.41M +8.5% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$106M -$24.2M -$11.7M -94.1% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$94.5M -$23.8M -$6.09M -34.4% 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 -$88.4M -$30M -$19.2M -179% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$69.2M -$28.3M -$19.8M -235% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$49.3M -$12.5M -$3.74M -42.8% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 -$45.6M -$17.7M -$11.7M -195% 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 -$33.9M -$10.7M -$7.42M -223% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$26.5M -$8.44M -$6.1M -261% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 -$20.4M -$8.73M -$6.86M -367% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$13.5M -$5.99M 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 -$3.32M 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$2.34M 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 -$1.87M 01 Jan 2018 31 Mar 2018 10-Q 21 Jun 2019

Applied Therapeutics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$104M -$39.8M -61.6% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$64.5M +$18.4M +22.2% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$83M +$22.7M +21.5% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024
2021 -$106M -$11.2M -11.8% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023
2020 -$94.5M -$48.9M -107% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022
2019 -$45.6M -$32.1M -237% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
2018 -$13.5M 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.